Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.

@article{Lotan2009ImpactOC,
  title={Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.},
  author={Yair Lotan and Umberto Capitanio and Shahrokh F Shariat and Georg C. Hutterer and Pierre I. Karakiewicz},
  journal={BJU international},
  year={2009},
  volume={103 10},
  pages={1368-74}
}
OBJECTIVE To determine whether the nuclear matrix protein-22 (NMP22) assay can improve the accuracy of discriminating between high-risk patients with and without bladder cancer. PATIENTS AND METHODS Age, gender, race, smoking status, haematuria and its extent, and the NMP22 and urinary cytology results, were available for 1272 patients. The data of 670 (52.7%) from four study sites were used to develop a logistic regression model-based nomogram to predict the presence of bladder cancer. The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Evaluation and work-up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey

  • AM Nieder, M Manoharan, S Vyas, M. Soloway
  • J Urol
  • 2007

Gender disparities in urologic referral of hematuria

  • E Johnson, S Daignault, Y Zhang
  • J Urol
  • 2006

Similar Papers

Loading similar papers…